Activation of Central Angiotensin Type 2 Receptors Suppresses Norepinephrine Excretion and Blood Pressure in Conscious Rats
Open Access
- 1 June 2011
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 24 (6), 724-730
- https://doi.org/10.1038/ajh.2011.33
Abstract
We have previously documented the finding that central angiotensin type 2 receptors (AT2R) negatively modulate sympathetic outflow and arterial blood pressure (BP). In this study, we investigated the effects of intracerebroventricular (icv) infusion of Compound 21 (C21), the first selective nonpeptide AT2R agonist, on norepinephrine (NE) excretion and BP in rats. C21 was infused icv for 7 days, using a micro-osmotic pump. Urinary NE concentration was measured using the NE enzyme immunoassay kit. BP was recorded by radiotelemetry. After 7 days, the rats were killed and three relevant samples from sympathetic brain regions and the cerebral cortex were obtained by micro-punching to measure neuronal nitric oxide synthase (nNOS) protein expression by western blot. In addition, the influence of C21 on neuronal potassium current (IKv) was determined by whole-cell patch-clamp in a neuron cell line, CATH.a. (i) Icv treatment with C21 significantly decreased both the concentration and the amount of NE in night time urine, but had no effect on daytime urine. (ii) C21-treated rats exhibited a slight but significant decrease in BP. (iii) The effects of C21 on NE excretion and BP were abolished by use of the AT2R antagonist, PD123319, and nitric oxide synthase (NOS) inhibitor, N-omega-nitro-L-arginine methyl ester (L-NAME). (iv) C21 treatment significantly upregulated nNOS expression in the paraventricular nucleus of the hypothalamus (PVN) and rostral ventrolateral medulla (RVLM), but not in the nucleus of the solitary tract (NTS) and cerebral cortex. (v) In CATH.a neurons, C21 treatment significantly increased IKv, and this increase was completely abolished by PD123319 and L-NAME. These results demonstrate a central inhibitory influence of C21 on sympathetic outflow by means of a nNOS-dependent mechanism that might be mediated by facilitating the neuronal potassium channel. American Journal of Hypertension, advance online publication 10 March 2011; doi:10.1038/ajh.2011.33Keywords
This publication has 29 references indexed in Scilit:
- Developmental changes in AT1 and AT2 receptor-protein expression in ratsJournal of the Renin-Angiotensin-Aldosterone System, 2010
- Stimulation of angiotensin AT2 receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive ratsBritish Journal of Pharmacology, 2010
- Imbalance of Angiotensin Type 1 Receptor and Angiotensin II Type 2 Receptor in the Rostral Ventrolateral MedullaHypertension, 2008
- Effects of Angiotensin Type 2 Receptor Overexpression in the Rostral Ventrolateral Medulla on Blood Pressure and Urine Excretion in Normal RatsHypertension, 2008
- Differential Mechanisms Underlying the Modulation of Delayed-Rectifier K+Channel in Mouse Neocortical Neurons by Nitric OxideJournal of Neurophysiology, 2006
- Electrophysiological Properties of Rostral Ventrolateral Medulla Neurons in Angiotensin II 1a Receptor Knockout MiceHypertension, 2005
- Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG IIAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 CellsJournal of Biological Chemistry, 2003
- Angiotensin-II Subtype 2 Receptor Agonist (CGP-42112) Inhibits Catecholamine Biosynthesis in Cultured Porcine Adrenal Medullary Chromaffin CellsBiochemical and Biophysical Research Communications, 2000
- Neuronal Ion Channel Signalling Pathways: Modulation by Angiotensin IICellular Signalling, 1998